On the mechanism of reversal of reserpine action by pargyline hydrochloride.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D003533:Cyproheptadine / Q000494:pharmacology; D004285:Dogs; D004837:Epinephrine / Q000032:analysis; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000032:analysis; D010293:Pargyline / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D011748:Pyrogallol / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology*; D014043:Tolazoline / Q000494:pharmacology
D008781:Methyltyrosines; D011748:Pyrogallol; D003533:Cyproheptadine; D001285:Atropine; D012110:Reserpine; D010293:Pargyline; D011433:Propranolol; D014043:Tolazoline; D009638:Norepinephrine; D004837:Epinephrine